Human endoglin-CD3 bispecific T cell engager antibody induces anti-tumor effect in vivo

The authors apologize for errors in the originally published version of this article that require correction. Mistaken images were used in Figure 5A (e), Figure 7 (Heart of the hEND-CD3/BiTE group), and Supplementary Figures S4A, S4C, and S6d. The authors have corrected the mistakenly used images and declare that these corrections do not change the conclusions of this article. The authors sincerely apologize to the journal and its readers for any confusion this may have caused. The corrected versions are provided below.

Figure A.

Corrected figure for original Figure 5A (e), Figure 7 (Heart of the hEND-CD3/BiTE group), and Supplementary Figure S6d.

Figure B.

Corrected figure for original Supplementary Figure S4A and C.